Several years experience in healthcare financial and strategic advisory working with Big Pharma and leading health institutions on projects ranging from physician compensation, value-based payment models, purchase price accounting, due diligence, and strategic forecasting. Mr. Delmonico received an MBA in Healthcare at Temple University where he also started Strados Labs after attending a healthcare hackathon at Jefferson University Health System

Mr. Powers was CIO of CardioMEMS. Under his leadership at CardioMEMS, Richard and his team designed and developed a secure, cloud-based, remote chronic disease management IoT platform powering the world’s first FDA-approved implantable wireless blood pressure sensor for patients with heart failure that showed a 50% hospitalization reduction rate and was acquired for $455M

Dr. Mitchell Glass is a 30-year veteran of the pharmaceutical industry. His experience is broad, ranging from senior positions in top ten pharmaceutical companies to investment in and management of start-ups and biotechs. He has successful exits and IPOs including AtheroGenix (NASDAQ, 2004) and dozens of successful trials.

25+ years experience in developing and commercializing medical device products. He has successfully led teams focused on integrating hardware sensor data with a remote patient monitoring platform for companies like CardioMEMs (acquired by St. Jude Medical of $455M in 2013) and Sarvint Technologies.